Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)

The University of Texas System (UT)

Status

Conditions: Uterine Sarcoma

Treatments: Drug: Everolimus

Study type: Expanded Access

Funder types: Other

Identifiers

NCT03493165

CTMS# 18-0020

Details and patient eligibility

About

Single patient treatment with everolimus.

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria